Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish Dureja

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
International Journal of Biological Macromolecules|June 11, 2021
Role of chitosan based nanomedicines in the treatment of chronic respiratory diseasesNisha Gulati, Kamal Dua, Harish Dureja
International Journal of Biological Macromolecules|August 13, 2019
Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potentialParijat Pandey, Kamal Dua, Harish Dureja
Recent Patents on Drug Delivery & Formulation|September 15, 2012
Co-processed excipients: a patent reviewNidhi Garg, Harish Dureja, Deepak Kaushik
Current Cancer Drug Targets|March 28, 2019
Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A ReviewSeema Rohilla, Harish Dureja, Vinay Chawla
Recent Patents on Nanotechnology|September 26, 2018
Nanosponges -A Promising Novel Drug Delivery SystemParijat Pandey, Deepika Purohit, Harish Dureja
Pharmaceutical Nanotechnology|October 7, 2017
Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation MethodMinakshi Gupta, Rakesh Kumar Marwaha, Harish Dureja
International Journal of Computational Biology and Drug Design|December 26, 2014
Detour matrix-based adjacent path eccentric distance sum indices for (Q)SAR/QSPR. Part II: application in development of models for COX-2 inhibitory activity of indomethacin derivativesMonika Singh, Harish Dureja, A K Madan
Journal of Chemotherapy (Florence, Italy)|October 26, 2023
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and <i>in vitro</i> cytotoxicity study against human HepG2 carcinoma cellsHarpreet Kaur Khanuja, Rajendra Awasthi, Harish Dureja
International Journal of Computational Biology and Drug Design|January 22, 2010
Topological models for prediction of physico-chemical, pharmacokinetic and toxicological properties of antihistaminic drugs using decision tree and moving average analysisHarish Dureja, Sunil Gupta, A K Madan
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2012
Classification models for safe drug moleculesA K Madan, Sanjay Bajaj, Harish Dureja
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
International Journal of Biological Macromolecules|June 11, 2021
Role of chitosan based nanomedicines in the treatment of chronic respiratory diseasesNisha Gulati, Kamal Dua, Harish Dureja
International Journal of Biological Macromolecules|August 13, 2019
Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potentialParijat Pandey, Kamal Dua, Harish Dureja
Recent Patents on Drug Delivery & Formulation|September 15, 2012
Co-processed excipients: a patent reviewNidhi Garg, Harish Dureja, Deepak Kaushik
Current Cancer Drug Targets|March 28, 2019
Cytoprotective Agents to Avoid Chemotherapy Induced Sideeffects on Normal Cells: A ReviewSeema Rohilla, Harish Dureja, Vinay Chawla
Recent Patents on Nanotechnology|September 26, 2018
Nanosponges -A Promising Novel Drug Delivery SystemParijat Pandey, Deepika Purohit, Harish Dureja
Pharmaceutical Nanotechnology|October 7, 2017
Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation MethodMinakshi Gupta, Rakesh Kumar Marwaha, Harish Dureja
International Journal of Computational Biology and Drug Design|December 26, 2014
Detour matrix-based adjacent path eccentric distance sum indices for (Q)SAR/QSPR. Part II: application in development of models for COX-2 inhibitory activity of indomethacin derivativesMonika Singh, Harish Dureja, A K Madan
Journal of Chemotherapy (Florence, Italy)|October 26, 2023
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and <i>in vitro</i> cytotoxicity study against human HepG2 carcinoma cellsHarpreet Kaur Khanuja, Rajendra Awasthi, Harish Dureja
International Journal of Computational Biology and Drug Design|January 22, 2010
Topological models for prediction of physico-chemical, pharmacokinetic and toxicological properties of antihistaminic drugs using decision tree and moving average analysisHarish Dureja, Sunil Gupta, A K Madan
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2012
Classification models for safe drug moleculesA K Madan, Sanjay Bajaj, Harish Dureja
Pageof 15